Condition: RAS/BRAF Wild Type Colorectal Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
This is a multicenter, open Phase Ib/II clinical study evaluating the safety and efficacy of TQB2922 in combination with TAS-102±bevacizumab in subjects with RAS/BRAF wild-type unresectable locally advanced or metastatic colorectal cancer that has failed treatment with oxaliplatin, fluorouracil-based and irinotecan.
This description comes directly from the study's public registry record.
Suxia Luo, Master · 18638553211 · luosxrm@163.com
Shegan Gao, Doctor · 18639859977 · gsg112258@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| National Cancer Center/Chinese Academy of Medical Sciences Cancer Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Zhongshan Hospital Affiliated to Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Meizhou People's Hospital | Meizhou, Guangdong, China | Not Yet Recruiting |
| Shantou University Medical College Affiliated Cancer Hospital | Shantou, Guangdong, China | Not Yet Recruiting |
| Guangxi Zhuang Autonomous Region Cancer Hospital | Nanning, Guangxi, China | Not Yet Recruiting |
| Harbin Medical University Cancer Hospital | Harbin, Heilongjiang, China | Not Yet Recruiting |
| Xinyang Central Hospital | Xinyang, Henan, China | Not Yet Recruiting |
| Zhoukou Central Hospital | Zhoukou, Henan, China | Not Yet Recruiting |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Not Yet Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07044908